- Home
- GRX vs CVRX Comparison
GRX vs CVRX Comparison
Compare GRX & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- CVRX
- Stock Information
- Founded
- GRX 2007
- CVRX 2000
- Country
- GRX United States
- CVRX United States
- Employees
- GRX N/A
- CVRX N/A
- Industry
- GRX Finance/Investors Services
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GRX Finance
- CVRX Health Care
- Exchange
- GRX Nasdaq
- CVRX Nasdaq
- Market Cap
- GRX 148.5M
- CVRX 174.4M
- IPO Year
- GRX N/A
- CVRX 2021
- Fundamental
- Price
- GRX $9.57
- CVRX $6.04
- Analyst Decision
- GRX
- CVRX Buy
- Analyst Count
- GRX 0
- CVRX 7
- Target Price
- GRX N/A
- CVRX $14.50
- AVG Volume (30 Days)
- GRX 39.7K
- CVRX 200.4K
- Earning Date
- GRX 01-01-0001
- CVRX 07-28-2025
- Dividend Yield
- GRX 5.98%
- CVRX N/A
- EPS Growth
- GRX N/A
- CVRX N/A
- EPS
- GRX 0.26
- CVRX N/A
- Revenue
- GRX N/A
- CVRX $52,870,000.00
- Revenue This Year
- GRX N/A
- CVRX $11.53
- Revenue Next Year
- GRX N/A
- CVRX $18.61
- P/E Ratio
- GRX $38.50
- CVRX N/A
- Revenue Growth
- GRX N/A
- CVRX 25.62
- 52 Week Low
- GRX $7.73
- CVRX $4.30
- 52 Week High
- GRX $10.40
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- GRX 49.33
- CVRX 46.70
- Support Level
- GRX $9.39
- CVRX $5.72
- Resistance Level
- GRX $9.69
- CVRX $6.22
- Average True Range (ATR)
- GRX 0.13
- CVRX 0.35
- MACD
- GRX 0.00
- CVRX 0.04
- Stochastic Oscillator
- GRX 44.46
- CVRX 44.17
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.